Guardant Health stock hits 52-week high at 64.74 USD
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Guardant Health Inc (GH)
Guardant Health Inc stock price live, this page displays NASDAQ GH stock exchange data. View the GH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Guardant Health Inc real time stock price chart below.
What Is the Guardant Health Inc Stock Price Today?
The Guardant Health Inc stock price today is 64.47.
What Is the Stock Symbol for Guardant Health Inc?
The stock symbol for Guardant Health Inc is ""GH.""
What Stock Exchange Does Guardant Health Inc Trade On?
Guardant Health Inc is listed and trades on the NASDAQ stock exchange.
Is Guardant Health Inc a Good Stock to Buy?
Determining whether Guardant Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GH quote. (ISIN: US40131M1099)
What Is the Guardant Health Inc Stock Price Today?
The Guardant Health Inc stock price today is 64.47.
What Is the Stock Symbol for Guardant Health Inc?
The stock symbol for Guardant Health Inc is ""GH.""
What Stock Exchange Does Guardant Health Inc Trade On?
Guardant Health Inc is listed and trades on the NASDAQ stock exchange.
Is Guardant Health Inc a Good Stock to Buy?
Determining whether Guardant Health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GH quote. (ISIN: US40131M1099)
Fair Value
An estimate of a Guardant Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
63.44
65.11
52 wk Range
20.14
65.11
GH Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
1/2
Fair Value
An estimate of a Guardant Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
63.4465.11
52 wk Range
20.1465.11
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Guardant Health's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
61.33
Downside
-4.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Guardant Health stock hits 52-week high at 53.49 USD
- Investing.com
- Guardant Health stock hits 52-week high at 60.69 USD
- Investing.com
- Guardant Health stock hits 52-week high at 64.74 USD
- Investing.com
- Guardant Health stock hits 52-week high at 60.69 USD
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Guardant Health Inc Company Profile
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Guardant Health Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue grew 31% YoY to $232.1M, beating forecasts; EPS of -$0.44 surpassed -$0.72 estimate
- Stock rose 4.32% after-hours; company launched 11 new smart liquid biopsy applications
- Full-year revenue guidance raised to $915-$925M; Shield revenue guidance increased to $55-$60M
- Company aims for cash flow breakeven by 2028; maintains strong liquidity with current ratio of 4.11
- Executives confident in financial trajectory; emphasize strategic importance of innovations in oncology
Last Updated: 30/07/2025, 23:34
Read Full TranscriptCompare GH to Peers and Sector
Metrics to compare | GH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.4x | −1.1x | −0.6x | |
PEG Ratio | −1.07 | −0.04 | 0.00 | |
Price/Book | −26.3x | 1.4x | 2.6x | |
Price / LTM Sales | 9.7x | 1.1x | 3.3x | |
Upside (Analyst Target) | −6.9% | 40.0% | 38.7% | |
Fair Value Upside | Unlock | 16.3% | 5.1% | Unlock |
Analyst Ratings
21 Buy
1 Hold
1 Sell
Ratings:
23 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 61.33
(-4.87% Downside)
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
-0.44 / -0.72
Revenue / Forecast
232.10M / 211.27M
People Also Watch
FAQ
What Stock Exchange Does Guardant Health Trade On?
Guardant Health is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Guardant Health?
The stock symbol for Guardant Health is "GH."
What Is the Guardant Health Market Cap?
As of today, Guardant Health market cap is 8.04B.
What Is Guardant Health's Earnings Per Share (TTM)?
The Guardant Health EPS (TTM) is -3.35.
When Is the Next Guardant Health Earnings Date?
Guardant Health will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is GH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Guardant Health Stock Split?
Guardant Health has split 0 times.
How Many Employees Does Guardant Health Have?
Guardant Health has 2010 employees.
What is the current trading status of Guardant Health (GH)?
As of 28 Aug 2025, Guardant Health (GH) is trading at a price of 64.47, with a previous close of 63.50. The stock has fluctuated within a day range of 63.44 to 65.11, while its 52-week range spans from 20.14 to 65.11.
What Is Guardant Health (GH) Price Target According to Analysts?
The average 12-month price target for Guardant Health is USD61.33333, with a high estimate of USD70 and a low estimate of USD47. 21 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Buy. The stock has an -4.87% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.